Clinical applications of the standard uptake values of the contrasted 18[F]FDG-PET/CT in nasopharyngeal carcinoma patients. by Ahmad Saad, Fathinul Fikri et al.
Clinical applications of the standard uptake values of the contrasted 18[F]FDG-
PET/CT in nasopharyngeal carcinoma patients. 
ABSTRACT 
Aim: To appraise the influence of the standard uptake values (SUV) of the contrasted 
[18F]fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography 
(CT) in TNM staging and its impact on the management plan in patients with nasopharyngeal 
carcinoma (NPC). Methods: We prospectively analysed the contrasted [18F]FDG-PET/CT 
findings of 14 consecutive patients (mean age 44.64 ± 15.03 years) with histologically proven 
NPC of WHO type II or type III. The referring surgeon was asked to prospectively assign a 
treatment plan for all patients being evaluated by [18F]FDG-PET/CT for the 7th edition of 
the American Joint Cancer Committee/Union Internationals Contre Cancer TNM staging 
system on CT. This treatment plan was then compared with that based on incremental 
information supplied by PET. The SUVmax and the widest dimension of the primary tumour, 
cervical lymph nodes and the distant metastatic lesions were quantified on the co-registered 
PET/CT images by two experienced nuclear radiologists. Results: The contrasted [18F]FDG-
PET/CT changed the management plan in 9 patients (64.7%). Mean primary tumour 
SUVmax, metastatic lymph node SUVmax and tumour size were 14.28 ± 9.10, 4.33 ± 0.99 
and 3.05 ± 2.44 cm2, respectively. Using bivariate analysis, there were significant 
correlations between the number of metastatic lymph nodes vs lymph node SUVmax and the 
N stage (r = 0.661, P < 0.01). Multiple linear regression analysis revealed the tumour 
SUVmax and the number of lymph nodes to be the predictors of the T stage (adjusted R2 = 
0.806, P < 0.05). Conclusions: While the tumour SUVmax and the number of lymph nodes 
may potentially be the surrogate markers for the T stage in the patients with NPC, the use of 
contrasted [18F]FDG-PET/CT has substantially changed the management strategy. 
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